Health Condition 1: C53- Malignant neoplasm of cervix uteri
Conditions
Interventions
Intervention1: Individualised Homoeopathic Medicine: Oral route administeration globule 30 size Centesimal scale
First dose using Boericke repertory one week post first radiotherapy session
Subseque
Sponsors
Bakson Homoeopathic Medical College and hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Females with confirmed diagnosis of cervical cancer undergoing standard chemo and or radiotherapy 2.Participants with a score of 0-2 on Eastern Cooperative Oncology Group ECOG performance scale
Exclusion criteria
Exclusion criteria: 1.Participants with uncontrolled systemic or psychiatric illnesses leading to cognitive impairment. 2.Participants diagnosed with metastatic cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected positive changes in scoring of scales EORTC QLQ-C30 and QLQ-CX24Timepoint: 15 months study 11 months enrolment Follow ups-for participants enrolled in first 7 months will be followed up monthly for 6 months For participants enrolled in last 3 months will be followed up monthly for 4 months Scales assessed every 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: N/A | — |
Countries
India
Contacts
Public ContactDr Shailja Upadhyay
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed